Short-term effect of a single levodopa dose on micturition disturbance in Parkinson's disease patients with the wearing-off phenomenon
- PMID: 12722172
- DOI: 10.1002/mds.10403
Short-term effect of a single levodopa dose on micturition disturbance in Parkinson's disease patients with the wearing-off phenomenon
Abstract
We investigated the short-term effects of a single dose of levodopa (L-dopa) on micturition function in PD patients with wearing-off phenomenon. Eighteen PD patients who had median Hoehn and Yahr scores of 5 during the off phase and 3 during the on phase were recruited. We carried out urodynamic studies before and about 1 hour after the patients had taken 100 mg of L-dopa with dopa-decarboxylase inhibitor (DCI). After taking the L-dopa/DCI, urinary urgency and urge incontinence aggravated, whereas voiding difficulty was alleviated in all 12 patients. When compared to the baseline assessment, urodynamic study results after taking 100 mg of L-dopa/DCI showed aggravated detrusor hyperreflexia; decreased maximum bladder capacity (P = 0.006); an increased maximum Watts Factor value (P = 0.001), reflecting the detrusor power on voiding; an increased Abrams-Griffiths number (P = 0.042), reflecting urethral obstruction on voiding; decreased residual urine volume (P = 0.025); and increased static urethral closure pressure (P = 0.012). One hundred milligrams of L-dopa/DCI worsened detrusor hyperreflexia, producing worsened urinary urgency and urge incontinence during the storage (bladder-filling) phase. It also increased detrusor contractility much more than it did urethral obstruction in the voiding phase, producing overall lessening of voiding difficulty and improving voiding efficiency in our PD patients with the wearing-off phenomenon.
Copyright 2003 Movement Disorder Society
Similar articles
-
Comparing bromocriptine effects with levodopa effects on bladder function in Parkinson's disease.Mov Disord. 2009 Dec 15;24(16):2386-90. doi: 10.1002/mds.22840. Mov Disord. 2009. PMID: 19908315 Clinical Trial.
-
[Benefit of L-DOPA-without-DCI (decarboxylase inhibitor) therapy on wearing-off phenomenon in advanced stages of Parkinson's disease patients].No To Shinkei. 2002 Feb;54(2):127-32. No To Shinkei. 2002. PMID: 11889758 Japanese.
-
Effects of dopaminergic treatment on bladder function in Parkinson's disease.Neurourol Urodyn. 2004;23(7):689-96. doi: 10.1002/nau.20054. Neurourol Urodyn. 2004. PMID: 15382192 Clinical Trial.
-
[Recommendations for the urodynamic examination in the investigation of non-neurological female urinary incontinence].Prog Urol. 2007 Nov;17(6 Suppl 2):1264-84. Prog Urol. 2007. PMID: 18214138 Review. French.
-
[Disturbance of micturition in Parkinson's disease].No To Shinkei. 2001 Nov;53(11):1009-14. No To Shinkei. 2001. PMID: 11761908 Review. Japanese. No abstract available.
Cited by
-
Neural control of the lower urinary tract.Compr Physiol. 2015 Jan;5(1):327-96. doi: 10.1002/cphy.c130056. Compr Physiol. 2015. PMID: 25589273 Free PMC article. Review.
-
Underactive and overactive bladders are related to motor function and quality of life in Parkinson's disease.Int Urol Nephrol. 2015 May;47(5):751-7. doi: 10.1007/s11255-015-0951-y. Epub 2015 Mar 20. Int Urol Nephrol. 2015. PMID: 25792006
-
Integrated control of lower urinary tract--clinical perspective.Br J Pharmacol. 2006 Feb;147 Suppl 2(Suppl 2):S14-24. doi: 10.1038/sj.bjp.0706629. Br J Pharmacol. 2006. PMID: 16465178 Free PMC article. Review.
-
Bladder, bowel, and sexual dysfunction in Parkinson's disease.Parkinsons Dis. 2011;2011:924605. doi: 10.4061/2011/924605. Epub 2011 Sep 12. Parkinsons Dis. 2011. PMID: 21918729 Free PMC article.
-
Bladder and bowel dysfunction in Parkinson's disease.J Neural Transm (Vienna). 2008;115(3):443-60. doi: 10.1007/s00702-007-0855-9. Epub 2008 Mar 10. J Neural Transm (Vienna). 2008. PMID: 18327532 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical